Kamran Mahmood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kamran Mahmood has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Scott L. Shofer
Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Duke University, Durham, North Carolina
11 shared publicationsMomen M. Wahidi
9 shared publicationsCoral X. Giovacchini
Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Duke University, Durham, North Carolina
7 shared publicationsJeffrey M. Clarke
Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina
5 shared publicationsMichael Dorry
Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Duke University, Durham, North Carolina
5 shared publicationsXiaofei Wang
4 shared publications
Latest Publications
- Open Access
- 7 March 2026
- Published by Elsevier in JTO Clinical and Research Reports
- Vol. 7 (8) , 100983
Safety and Efficacy of Bronchoscopic Pulsed Electric Field Ablation for Lung Cancer and Metastases
- 7 March 2026
- Published by Elsevier in JTO Clinical and Research Reports
- Vol. 7 (8) , 100983
Open AccessSafety and Efficacy of Bronchoscopic Pulsed Electric Field Ablation for Lung Cancer and Metastases
- 2 January 2026
- Published by Springer Nature
- p. 359-367
Malignant Central Airway Obstruction
- Open Access
- 1 September 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (9) , 6652-6660
Endobronchial ultrasound diagnostic yield for sarcoidosis in hilar vs. mediastinal lymph nodes
Background: Pulmonary sarcoidosis is diagnosed by endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA) of hilar and mediastinal lymph nodes and the finding of non-caseating granulomatous inflammation. There are currently no guidelines about which lymph node stations to sample to optimize the diagnostic yield and it is unclear if there is a difference in the yield between hilar and mediastinal lymph node stations. The objective of this study was to assess the difference in the diagnostic yield of EBUS-TBNA for non-caseating granulomas between hilar and mediastinal lymph nodes. Methods: A retrospective study was performed and medical records were reviewed of all patients at a single institution who underwent EBUS-TBNA of thoracic lymph nodes to evaluate for sarcoidosis. Results: Two hundred twenty-five patients with suspicion of sarcoidosis underwent EBUS-TBNA for evaluation of hilar and mediastinal lymphadenopathy. The yield of EBUS-TBNA for non-caseating granulomas was 61.8% vs. 65.5%, P=0.46, for hilar and mediastinal lymph nodes, respectively. The sensitivity for sarcoidosis of EBUS-TBNA of hilar vs. mediastinal nodes was 66.9% [95% confidence interval (CI): 58.9–74.9%] vs. 71.1% (95% CI: 65.3–76.9%). The specificity for sarcoidosis of EBUS-TBNA of both hilar and mediastinal nodes was 100%. The diagnostic yield for non-caseating granulomas in patients who underwent hilar nodes biopsy only, mediastinal nodes biopsy only, and both hilar and mediastinal nodes biopsy was 71.4%, 67%, and 73.1%, respectively (P=0.63). In multivariable logistic regression analysis, the diagnostic yield of EBUS-TBNA was only associated with age [odds ratio (OR) 0.96; 95% CI: 0.94–0.98; PConclusions: The yield of EBUS-TBNA for non-caseating granulomas in patients with suspected sarcoidosis was similar between the hilar and mediastinal lymph nodes.
- 1 September 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (9) , 6652-6660
Open AccessEndobronchial ultrasound diagnostic yield for sarcoidosis in hilar vs. mediastinal lymph nodes
Background: Pulmonary sarcoidosis is diagnosed by endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA) of hilar and mediastinal lymph nodes and the finding of non-caseating granulomatous inflammation. There are currently no guidelines about which lymph node stations to sample to optimize the diagnostic yield and it is unclear if there is a difference in the yield between hilar and mediastinal lymph node stations. The objective of this study was to assess the difference in the diagnostic yield of EBUS-TBNA for non-caseating granulomas between hilar and mediastinal lymph nodes. Methods: A retrospective study was performed and medical records were reviewed of all patients at a single institution who underwent EBUS-TBNA of thoracic lymph nodes to evaluate for sarcoidosis. Results: Two hundred twenty-five patients with suspicion of sarcoidosis underwent EBUS-TBNA for evaluation of hilar and mediastinal lymphadenopathy. The yield of EBUS-TBNA for non-caseating granulomas was 61.8% vs. 65.5%, P=0.46, for hilar and mediastinal lymph nodes, respectively. The sensitivity for sarcoidosis of EBUS-TBNA of hilar vs. mediastinal nodes was 66.9% [95% confidence interval (CI): 58.9–74.9%] vs. 71.1% (95% CI: 65.3–76.9%). The specificity for sarcoidosis of EBUS-TBNA of both hilar and mediastinal nodes was 100%. The diagnostic yield for non-caseating granulomas in patients who underwent hilar nodes biopsy only, mediastinal nodes biopsy only, and both hilar and mediastinal nodes biopsy was 71.4%, 67%, and 73.1%, respectively (P=0.63). In multivariable logistic regression analysis, the diagnostic yield of EBUS-TBNA was only associated with age [odds ratio (OR) 0.96; 95% CI: 0.94–0.98; PConclusions: The yield of EBUS-TBNA for non-caseating granulomas in patients with suspected sarcoidosis was similar between the hilar and mediastinal lymph nodes.
- 9 May 2025
- Published by Springer Nature
- p. 1-10
Malignant Central Airway Obstruction
- Open Access
EBUS Diagnostic Yield for Sarcoidosis in Hilar vs. Mediastinal Lymph Nodes
Background Pulmonary sarcoidosis is diagnosed by endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA) of hilar and mediastinal lymph nodes and the finding of non-caseating granulomatous inflammation. There are currently no guidelines about which lymph node stations to sample to optimize the diagnostic yield and it is unclear if there is a difference in the yield between hilar and mediastinal lymph node stations. Methods A retrospective study was performed to assess the difference in the diagnostic yield of EBUS-TBNA for non-caseating granulomas between hilar and mediastinal lymph nodes. Results Two hundred twenty-five patients with suspicion of sarcoidosis underwent EBUS-TBNA for evaluation of hilar and mediastinal lymphadenopathy. The yield of EBUS-TBNA for non-caseating granulomas was 61.8% vs. 65.5%, P = 0.46, for hilar and mediastinal lymph nodes, respectively. The sensitivity for sarcoidosis of EBUS-TBNA of hilar vs. mediastinal nodes was 66.9% (95% confidence interval or CI, 58.9%-74.9%) vs. 71.1% (95% CI, 65.3%-76.9%). The specificity for sarcoidosis of EBUS-TBNA of both hilar and mediastinal nodes was 100%. The diagnostic yield for non-caseating granulomas in patients who underwent hilar nodes biopsy only, mediastinal nodes biopsy only, and both hilar and mediastinal nodes biopsy was 71.4%, 67%, and 73.1%, respectively (P=0.63). In multivariable logistic regression analysis, the diagnostic yield of EBUS-TBNA was only associated with age (OR 0.96; 95% CI 0.94-0.98; P Conclusions The yield of EBUS-TBNA for non-caseating granulomas in patients with suspected sarcoidosis was similar between the hilar and mediastinal lymph nodes.
Open AccessEBUS Diagnostic Yield for Sarcoidosis in Hilar vs. Mediastinal Lymph Nodes
Background Pulmonary sarcoidosis is diagnosed by endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA) of hilar and mediastinal lymph nodes and the finding of non-caseating granulomatous inflammation. There are currently no guidelines about which lymph node stations to sample to optimize the diagnostic yield and it is unclear if there is a difference in the yield between hilar and mediastinal lymph node stations. Methods A retrospective study was performed to assess the difference in the diagnostic yield of EBUS-TBNA for non-caseating granulomas between hilar and mediastinal lymph nodes. Results Two hundred twenty-five patients with suspicion of sarcoidosis underwent EBUS-TBNA for evaluation of hilar and mediastinal lymphadenopathy. The yield of EBUS-TBNA for non-caseating granulomas was 61.8% vs. 65.5%, P = 0.46, for hilar and mediastinal lymph nodes, respectively. The sensitivity for sarcoidosis of EBUS-TBNA of hilar vs. mediastinal nodes was 66.9% (95% confidence interval or CI, 58.9%-74.9%) vs. 71.1% (95% CI, 65.3%-76.9%). The specificity for sarcoidosis of EBUS-TBNA of both hilar and mediastinal nodes was 100%. The diagnostic yield for non-caseating granulomas in patients who underwent hilar nodes biopsy only, mediastinal nodes biopsy only, and both hilar and mediastinal nodes biopsy was 71.4%, 67%, and 73.1%, respectively (P=0.63). In multivariable logistic regression analysis, the diagnostic yield of EBUS-TBNA was only associated with age (OR 0.96; 95% CI 0.94-0.98; P Conclusions The yield of EBUS-TBNA for non-caseating granulomas in patients with suspected sarcoidosis was similar between the hilar and mediastinal lymph nodes.
- Top Cited Papers
Management of Central Airway Obstruction
- 6 June 2024
- Published by Elsevier in Lung Cancer
- Vol. 193, 107847
Differences in microenvironment of lung cancer and pleural effusions by single-cell RNA sequencing
- 6 June 2024
- Published by Elsevier in Lung Cancer
- Vol. 193, 107847
Differences in microenvironment of lung cancer and pleural effusions by single-cell RNA sequencing
- Open Access
- 1 September 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (9) , 4717-4724
Prevention of contamination after endotracheal intubation using a dedicated sleeve
Background: Contamination of work surfaces by used laryngoscopes after endotracheal intubation is a serious infection control concern but no strategies are available to address it. We assessed if contamination of the surfaces after endotracheal intubation would be reduced when providers used a dedicated, self-erected, disposable plastic sleeve (BladePouch) to store the used laryngoscope as compared to using single gloves or double gloves and sheathing the laryngoscope with the outer gloves. Methods: Twenty participants were recruited including attending physicians, trainees and allied health care professionals. They performed endotracheal intubation on a mannequin with oral cavity coated with a dye and stored the used laryngoscope blade using single gloves, double gloves or BladePouch. Each participant used both direct and video laryngoscopes. Following intubation, dye contamination of gloves, gown and work surface was evaluated. Results: There was no difference in the contamination of gloves or gowns between the single gloves, double gloves or BladePouch groups. However, work surface contamination was significantly reduced when using BladePouch compared to single or double gloves (13% vs. 100% vs. 80% respectively, Pvs. single or double gloves, even when adjusted for intubation device, role and experience of participants with an adjusted odds ratio of 0.0054 (95% confidence interval: 0.0009–0.0314), PConclusions: In conjunction with standard precautions, the use of a dedicated plastic sleeve to store contaminated laryngoscope blade after endotracheal intubation may reduce the work surface contamination, independent of intubation device, role and experience of providers.
- 1 September 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (9) , 4717-4724
Open AccessPrevention of contamination after endotracheal intubation using a dedicated sleeve
Background: Contamination of work surfaces by used laryngoscopes after endotracheal intubation is a serious infection control concern but no strategies are available to address it. We assessed if contamination of the surfaces after endotracheal intubation would be reduced when providers used a dedicated, self-erected, disposable plastic sleeve (BladePouch) to store the used laryngoscope as compared to using single gloves or double gloves and sheathing the laryngoscope with the outer gloves. Methods: Twenty participants were recruited including attending physicians, trainees and allied health care professionals. They performed endotracheal intubation on a mannequin with oral cavity coated with a dye and stored the used laryngoscope blade using single gloves, double gloves or BladePouch. Each participant used both direct and video laryngoscopes. Following intubation, dye contamination of gloves, gown and work surface was evaluated. Results: There was no difference in the contamination of gloves or gowns between the single gloves, double gloves or BladePouch groups. However, work surface contamination was significantly reduced when using BladePouch compared to single or double gloves (13% vs. 100% vs. 80% respectively, Pvs. single or double gloves, even when adjusted for intubation device, role and experience of participants with an adjusted odds ratio of 0.0054 (95% confidence interval: 0.0009–0.0314), PConclusions: In conjunction with standard precautions, the use of a dedicated plastic sleeve to store contaminated laryngoscope blade after endotracheal intubation may reduce the work surface contamination, independent of intubation device, role and experience of providers.